Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06732453 · ClinicalTrials.gov registry record · NA
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
A NA study of Gastroparesis and Functional Dyspepsia, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06732453: Recruiting NA study of Gastroparesis and Functional Dyspepsia, sponsored by Wake Forest University Health Sciences.
NCT06732453 is a NA study of Gastroparesis and Functional Dyspepsia that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06732453, a NA study of Gastroparesis and Functional Dyspepsia, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to assess whether using a yoga-based intervention in practice is feasible (possible) and acceptable to patients with Functional Dyspepsia and/or Gastroparesis (FD-GP).
Primary Outcome
Tracking the number of screened participants, those who are eligible, and the percent who agree to participate.
Conditions Studied
Interventions
- OTHER Seated Yoga Skills Training in Functional Dyspepsia and Gastroparesis (FD-GP)
Study Locations (1)
North Carolina
- Atrium Health Gastroenterology and Hepatology Kenilworth - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06732453 shows while recruiting
NCT06732453 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Seated Yoga Skills Training in Functional Dyspepsia and Gastroparesis (FD-GP) is the first listed.
NCT06732453 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06732453 about?
NCT06732453 is a clinical study titled "Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)". The purpose of this research study is to assess whether using a yoga-based intervention in practice is feasible (possible) and acceptable to patients with Functional Dyspepsia and/or Gastroparesis (FD-GP).
What is the current status of trial NCT06732453?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-06-18. Estimated completion is 2026-06.
What conditions does trial NCT06732453 study?
This clinical trial studies the following conditions: Gastroparesis, Functional Dyspepsia.
What interventions are being tested in trial NCT06732453?
The interventions under investigation include: Seated Yoga Skills Training in Functional Dyspepsia and Gastroparesis (FD-GP) (OTHER).
Who is sponsoring clinical trial NCT06732453?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06732453 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06732453's enrollment target sits among peer trials
10 41st of 44 higher than 2 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI